Jun-sheng Ni

681 total citations
28 papers, 484 citations indexed

About

Jun-sheng Ni is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jun-sheng Ni has authored 28 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Jun-sheng Ni's work include RNA modifications and cancer (8 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Jun-sheng Ni is often cited by papers focused on RNA modifications and cancer (8 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Jun-sheng Ni collaborates with scholars based in China, United States and United Kingdom. Jun-sheng Ni's co-authors include Weiping Zhou, Yuan Yang, Zhenguang Wang, Hao Zheng, Yonggang Hong, Ze‐Ya Pan, Hongli Yan, Zhiping Huang, Mengchao Wu and Zhangwei Yang and has published in prestigious journals such as Scientific Reports, Oncotarget and IEEE Wireless Communications.

In The Last Decade

Jun-sheng Ni

26 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun-sheng Ni China 15 335 206 74 54 52 28 484
Lexiang Zeng China 10 246 0.7× 166 0.8× 57 0.8× 37 0.7× 36 0.7× 19 440
Chengwu Zhang China 12 245 0.7× 143 0.7× 61 0.8× 52 1.0× 59 1.1× 28 459
Xiaohong Du China 12 237 0.7× 166 0.8× 58 0.8× 22 0.4× 49 0.9× 19 374
Wenli Diao China 16 345 1.0× 206 1.0× 143 1.9× 47 0.9× 65 1.3× 29 655
Zhenzhen Xu China 13 268 0.8× 181 0.9× 215 2.9× 34 0.6× 72 1.4× 28 575
Qianwei Ye China 11 253 0.8× 219 1.1× 126 1.7× 119 2.2× 95 1.8× 15 511
Libo Yin Germany 12 250 0.7× 176 0.9× 61 0.8× 37 0.7× 25 0.5× 16 395
Xu–Ting Zhi China 12 232 0.7× 189 0.9× 143 1.9× 99 1.8× 64 1.2× 31 543
Jinhua Song China 9 180 0.5× 128 0.6× 106 1.4× 29 0.5× 61 1.2× 35 390
Kamal Shaik Fakiruddin Malaysia 10 240 0.7× 105 0.5× 172 2.3× 22 0.4× 32 0.6× 14 429

Countries citing papers authored by Jun-sheng Ni

Since Specialization
Citations

This map shows the geographic impact of Jun-sheng Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun-sheng Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun-sheng Ni more than expected).

Fields of papers citing papers by Jun-sheng Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun-sheng Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun-sheng Ni. The network helps show where Jun-sheng Ni may publish in the future.

Co-authorship network of co-authors of Jun-sheng Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Jun-sheng Ni. A scholar is included among the top collaborators of Jun-sheng Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun-sheng Ni. Jun-sheng Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Yanbin, Shuwen Chen, Hao Deng, et al.. (2025). Targeting NAT10 Inhibits Hepatocarcinogenesis via ac4C‐Mediated SMAD3 mRNA Stability. Exploration. 5(6). 20250075–20250075.
2.
3.
Wang, Yiming, et al.. (2024). Integration of smart buildings with high penetration of storage systems in isolated 100 % renewable microgrids. Journal of Energy Storage. 105. 114633–114633. 2 indexed citations
4.
5.
Ni, Jun-sheng, et al.. (2024). Reliability-Centric Maintenance Planning for Bridge Infrastructure: A Novel Method Based on Improved Electric Fish Optimization. Buildings. 14(11). 3583–3583. 2 indexed citations
6.
Ni, Jun-sheng, Siyuan Fu, Zongyan Wang, et al.. (2024). Interleukin‐17A educated hepatic stellate cells promote hepatocellular carcinoma occurrence through fibroblast activation protein expression. The Journal of Gene Medicine. 26(6). e3693–e3693. 5 indexed citations
7.
Zheng, Hao, Zhangjun Cheng, Bo Liang, et al.. (2023). N6-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone Metastasis. International Journal of Biological Sciences. 19(4). 1009–1023. 21 indexed citations
8.
9.
Ye, Xin, Liping Wang, Cong Han, et al.. (2022). Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis. Annals of Translational Medicine. 10(6). 304–304. 26 indexed citations
10.
Ni, Jun-sheng, Hao Zheng, Zhenguang Wang, et al.. (2020). miR-515–5p suppresses HCC migration and invasion via targeting IL6/JAK/STAT3 pathway. Surgical Oncology. 34. 113–120. 38 indexed citations
11.
Zheng, Jingjing, Hong‐Tao Xu, Zheng Sun, et al.. (2020). Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer. Technology in Cancer Research & Treatment. 19. 1079173473–1079173473. 25 indexed citations
12.
Hong, Yonggang, Guanyu Yu, Qizhi Liu, et al.. (2019). The RNA binding protein neuro‐oncological ventral antigen 1 (NOVA1) regulates IL-6 mRNA stability to enhance JAK2-STAT3 signaling in CRC. Surgical Oncology. 31. 67–74. 14 indexed citations
13.
Hu, Yiren, et al.. (2019). miR-455-5p suppresses hepatocellular carcinoma cell growth and invasion via IGF-1R/AKT/GLUT1 pathway by targeting IGF-1R. Pathology - Research and Practice. 215(12). 152674–152674. 34 indexed citations
14.
15.
Wang, Jian, Zhitao Wu, Guoyu Pan, et al.. (2017). Enhanced doxorubicin delivery to hepatocellular carcinoma cells via CD147 antibody-conjugated immunoliposomes. Nanomedicine Nanotechnology Biology and Medicine. 14(6). 1949–1961. 40 indexed citations
16.
Zheng, Hao, Yuan Yang, Meng‐chao Wang, et al.. (2016). Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy. Surgical Oncology. 25(3). 171–177. 11 indexed citations
17.
Wang, Zhenguang, Hao Zheng, Wei Gao, et al.. (2016). eIF5B increases ASAP1 expression to promote HCC proliferation and invasion. Oncotarget. 7(38). 62327–62339. 23 indexed citations
18.
Pan, Ze‐Ya, Hào Pān, Jin Zhang, et al.. (2015). Lentivirus mediated silencing of Ubiquitin Specific Peptidase 39 inhibits cell proliferation of human hepatocellular carcinoma cells in vitro. Biological Research. 48(1). 18–18. 20 indexed citations
19.
Ni, Jun-sheng, et al.. (2014). MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells. European Journal of Histochemistry. 58(1). 2262–2262. 21 indexed citations
20.
Ni, Jun-sheng, Wan Yee Lau, Yuan Yang, et al.. (2013). A Prospective Randomized Controlled Trial to Compare Pringle Manoeuvre with Hemi-hepatic Vascular Inflow Occlusion in Liver Resection for Hepatocellular Carcinoma with Cirrhosis. Journal of Gastrointestinal Surgery. 17(8). 1414–1421. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lexiang Zeng Breakdown of academic impact, for papers by Chengwu Zhang Breakdown of academic impact, for papers by Xiaohong Du Breakdown of academic impact, for papers by Wenli Diao Breakdown of academic impact, for papers by Zhenzhen Xu Breakdown of academic impact, for papers by Qianwei Ye Breakdown of academic impact, for papers by Libo Yin Breakdown of academic impact, for papers by Xu–Ting Zhi Breakdown of academic impact, for papers by Jinhua Song Breakdown of academic impact, for papers by Kamal Shaik Fakiruddin
Rankless by CCL
2026